Autoimmune-acquired coagulation factor V deficiency with hyperfibrinolytic disseminated intravascular coagulation

Int J Lab Hematol. 2024 Apr;46(2):395-399. doi: 10.1111/ijlh.14218. Epub 2023 Dec 19.

Authors

Yuto Kaneda¹, Kenji Fukuno¹, Hiroki Minami², Yuri Nonaka², Akiko Horinoue², Yasunori Kuroki², Tsukasa Osaki^{3

4}, Masayoshi Souri^{3

4}, Hidesaku Asakura^{4

5}, Akitada Ichinose^{3

4}

Affiliations

¹ Department of Hematology, Takayama Red Cross Hospital, Gifu, Japan.
² Inspection Department, Takayama Red Cross Hospital, Gifu, Japan.
³ Yamagata University School of Medicine, Yamagata, Japan.
⁴ The Japanese Collaborative Research Group on Acquired Coagulopathies Supported by the Japanese Ministry of Health, Labor, and Welfare, Yamagata, Japan.
⁵ Department of Hematology, Kanazawa University Hospital, Kanazawa, Japan.

PMID: 38112128
DOI: 10.1111/ijlh.14218

No abstract available

Publication types

Letter

MeSH terms

Activated Protein C Resistance*
Blood Coagulation
Blood Coagulation Disorders*
Disseminated Intravascular Coagulation* / etiology
Factor V / genetics
Factor V Deficiency* / complications
Factor V Deficiency* / genetics
Humans

Substances

Factor V

Supplementary concepts

Thrombophilia due to Activated Protein C Resistance